One of the tragic realities of cancer is that the drugs used to treat it are highly toxic and their effectiveness varies unpredictably from patient to patient. However, a new "tumor-in-a-dish" technology is poised to change ...
Oct 28, 2014
1
0
Drug combinations used for the treatment of non-small-cell lung cancer (NSCLC) and melanoma aren't as effective as they could be. Oncologists haven't had the right tools to predict drug interactions, other than in costly ...
Feb 21, 2019
0
25
For decades, doctors and scientists have predicted that personalized medicine—tailoring drug doses and combinations to people's specific diseases and body chemistry—would be the future of health care.
Apr 7, 2016
0
46
A team of Singapore based scientists have found that pairing a new approach with an old drug may be an effective approach to treat common cancers. In a landmark study, Professor David Virshup and Dr. Jit Kong Cheong, from ...
Mar 23, 2015
0
29
A preclinical study led by Monash University has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular carcinoma ...
Sep 14, 2023
0
34
NYU School of Medicine researchers have discovered that dendritic cells in the liver have a protective role against the toxicity of acetaminophen, the widely used over-the-counter pain reliever and fever reducer for adults ...
Sep 1, 2011
0
0
(Medical Xpress) -- A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical results is not ...
Jun 13, 2012
0
0
Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours.
Apr 4, 2022
0
17
Liver cancer is one of the most common cancer types worldwide and is especially common in China. A collaborative effort between researchers at the Netherlands Cancer Institute and Shanghai using CRISPR/Cas has led to the ...
Jul 21, 2021
0
184
US regulators on Friday approved Harvoni, a daily pill to treat hepatitis C that is simpler to administer than long-standing treatments but that carries a steep price tag.
Oct 10, 2014
1
0
